Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM79 Inhibitors

The chemical class of TMEM79 Inhibitors encompasses a diverse range of compounds that influence cellular pathways and processes associated with TMEM79. These inhibitors act on various signaling cascades and cellular mechanisms that can modulate the activity or expression of TMEM79. Primarily, these inhibitors target key cellular signaling pathways such as PI3K/Akt/mTOR, MAPK/ERK, and stress-activated pathways. For instance, compounds like Rapamycin and LY 294002 focus on the mTOR and PI3K pathways, respectively, which are integral in regulating cell growth, proliferation, and survival. These pathways may intersect with TMEM79's role in the cell, thus influencing its activity. Similarly, inhibitors like Wortmannin and SB 203580, which target PI3K and p38 MAP kinase, respectively, could modulate TMEM79's function through alterations in signaling pathways related to stress response and inflammation. Furthermore, compounds like Trichostatin A and Bafilomycin A1, targeting histone deacetylase and V-ATPase, respectively, represent a focus on epigenetic regulation and lysosomal function. These aspects are crucial for gene expression regulation and intracellular trafficking, processes in which TMEM79 might be involved. By influencing these mechanisms, the compounds indirectly affect the functional dynamics of TMEM79.

Additionally, metabolic inhibitors such as 2-Deoxy-D-glucose play a role in this class by impacting the metabolic pathways. Since cellular metabolism is intricately linked with various signaling pathways, any alteration in metabolic processes can have downstream effects on TMEM79's activity or expression. The inhibitors in this class also include compounds like Thapsigargin and Cyclosporin A, which target calcium signaling and calcineurin, respectively. Calcium signaling is pivotal in numerous cellular functions, and its modulation can have widespread effects on various proteins, including TMEM79. In summary, TMEM79 Inhibitors as a chemical class comprises a spectrum of compounds that target multiple cellular processes and pathways. By modulating these pathways, they influence TMEM79's role and function in the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR pathway, potentially reducing TMEM79 related signaling involved in cell growth.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, could alter signaling pathways intersecting with TMEM79's cellular roles.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Histone deacetylase inhibitor, might affect chromatin remodeling associated with TMEM79 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, possibly influencing TMEM79 related pathways through phosphoinositide signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAP kinase inhibitor, could affect stress response pathways linked with TMEM79.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, potentially modulating MAPK/ERK pathways interacting with TMEM79.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, might impact stress signaling pathways associated with TMEM79 function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK inhibitor, potentially influencing pathways related to TMEM79 through MAPK/ERK modulation.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

V-ATPase inhibitor, could affect lysosomal function and pathways intersecting with TMEM79.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$65.00
$210.00
26
(2)

Glycolysis inhibitor, might influence metabolic pathways related to TMEM79's cellular role.